Multiple Myeloma Coverage from Every Angle

Mark Bustoros, MD, on How to Discuss Preventing or Delaying a Patient’s Treatment

Posted: Thursday, December 19, 2019

Mark Bustoros, MD, of Dana-Farber Cancer Institute, discusses the best way to approach patients with smoldering multiple myeloma about undergoing treatment that may be linked to side effects, but may prevent or delay the onset of active disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.